Commercial-stage life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing.
Disruptive animal health provider delivering innovative diagnostic solutions to veterinarians and pet owners across the United States.
Clinical-stage biotechnology company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV).
Clinical-stage biotechnology company focused on enabling cures with hematopoietic stem cell therapies.
Merged with Amplitude Healthcare Acquisition Corporation in 2021
Clinical-stage biotechnology company focused on developing transformative genome-edited allogeneic cell therapies for devastating human diseases.
Completed IPO in 2021
Clinical-stage biotechnology company pursuing the development of novel small molecules that target cancer through its dependency on stress support pathways.
Clinical-stage immuno-oncology company that aims to discover and develop potential best-in-class antibody therapies for the treatment of patients with cancer.
Clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease.
Completed IPO in 2021
Commercial-stage specialty pharmaceutical company focused on pain management and adjacent specialty therapeutics areas.
Acquired by Zydus in 2017
Clinical-stage ophthalmic company focused on novel therapeutics to address unmet medical needs, providing for the restoration, preservation, and improvement of patient vision and quality of life.
Commercial-stage specialty ophthalmic company focused on innovative and impactful branded prescription products targeting the anterior segment of the eye.
Acquired by Santen in 2020
Commercial-stage specialty pharmaceutical company focused on gastrointestinal, dermatological, and women’s health products.
Clinical-stage therapeutics company focused on the central nervous system (CNS), orphan diseases, and conditions with high unmet medical need.